← FDA DRUG APPROVALS

FDA ANDA · ANDA087689

CHLORTHALIDONE

Sponsor: ANI PHARMS

APPLICATION
ANDA087689
TYPE
ANDA
ORIGINAL APPROVAL
1981-09-16
LATEST ACTION
1994-09-14
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CHLORTHALIDONEDiscontinued
CHLORTHALIDONE 50MG · TABLET · ORAL

Approval history

1994-09-14Manufacturing (CMC) · Supplement 22AP
1994-03-04Labeling · Supplement 20AP
1991-05-31Manufacturing (CMC) · Supplement 18AP
1991-01-28Manufacturing (CMC) · Supplement 19AP
1990-06-29Manufacturing (CMC) · Supplement 17AP
1988-04-11Manufacturing (CMC) · Supplement 14AP
1988-04-11Manufacturing (CMC) · Supplement 13AP
1988-02-12Manufacturing (CMC) · Supplement 15AP
1986-05-02Manufacturing (CMC) · Supplement 10AP
1986-05-02Manufacturing (CMC) · Supplement 9AP
1986-05-02Manufacturing (CMC) · Supplement 11AP
1986-04-12Manufacturing (CMC) · Supplement 6AP
1985-08-09Manufacturing (CMC) · Supplement 8AP
1985-08-09Manufacturing (CMC) · Supplement 7AP
1984-06-29Manufacturing (CMC) · Supplement 5AP
1984-01-30Manufacturing (CMC) · Supplement 4AP
1983-02-28Manufacturing (CMC) · Supplement 1AP
1982-12-23Manufacturing (CMC) · Supplement 2AP
1981-09-16OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →